Patel Nirav P, Ahmed Murtuza, Rosen Ilene
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.
Chest. 2007 Nov;132(5):1664-71. doi: 10.1378/chest.06-1801.
Obstructive sleep apnea (OSA) is a common disorder associated with serious health consequences, increased health-care utilization, and economic burden. With greater public and medical attention to sleep disorders, the volume of referrals for sleep studies over the last decade has increased by approximately 12-fold. Despite the steep growth of infrastructure to diagnose and treat OSA, access to such services remains a sizeable problem, and demand overwhelms capacity. To expedite diagnosis of sleep apnea and prescription of treatment, one strategy adopted by sleep specialists is to employ split-night polysomnography, a strategy that encompasses both diagnosis of OSA and initiation of positive pressure therapy in a single night. This article reviews the literature examining this combined diagnostic/therapeutic strategy and discusses the applicable third-party issues of procedural coding and reimbursement.
阻塞性睡眠呼吸暂停(OSA)是一种常见疾病,会带来严重的健康后果、增加医疗保健利用率并造成经济负担。随着公众和医学界对睡眠障碍的关注度提高,过去十年中睡眠研究的转诊量增加了约12倍。尽管用于诊断和治疗OSA的基础设施急剧增长,但获得此类服务仍然是一个相当大的问题,需求远远超过了能力。为了加快睡眠呼吸暂停的诊断和治疗处方,睡眠专家采用的一种策略是采用分夜多导睡眠图,即在一个晚上同时进行OSA诊断和启动正压治疗的策略。本文回顾了研究这种联合诊断/治疗策略的文献,并讨论了程序编码和报销方面适用的第三方问题。